Nx Gen Sequencing Optic Atrophy Test is a cutting-edge diagnostic tool available at DNA Labs UAE, designed to identify genetic mutations associated with optic atrophy, a condition characterized by the damage or degeneration of the optic nerves, which can lead to vision impairment or loss. By utilizing Next Generation Sequencing (NGS) technology, this test can accurately analyze multiple genes simultaneously, offering a comprehensive understanding of the genetic underpinnings of optic atrophy. This is particularly crucial for early diagnosis, patient management, and in some cases, guiding treatment options. The test is priced at 5730 AED, reflecting the advanced technology and expertise required to perform this sophisticated analysis. Through this test, patients and healthcare providers can gain invaluable insights into the genetic causes of optic atrophy, facilitating informed decisions regarding care and management.
The "Nx Gen Sequencing Retinitis Pigmentosa Test" offered by DNA Labs UAE represents a cutting-edge genetic screening aimed at diagnosing Retinitis Pigmentosa (RP), a group of genetic disorders that cause retinal degeneration and, consequently, vision loss. This test leverages Next Generation Sequencing (NGS) technology to meticulously analyze the genetic makeup of individuals, identifying mutations in the genes known to be associated with RP. By doing so, it enables early detection and a better understanding of the specific type of RP a patient might have, facilitating personalized management and treatment plans.
Priced at 5730 AED, the test is a significant investment in personal health, particularly for those with a family history of Retinitis Pigmentosa or related symptoms. Conducted at DNA Labs UAE, a facility renowned for its state-of-the-art genetic testing services, clients can expect a thorough and reliable diagnostic process. This test is especially valuable for families seeking clarity on their genetic health, enabling informed decisions about future generations' risk of inheriting RP.
The Nx Gen Sequencing Usher Syndrome Test is a cutting-edge diagnostic tool available at DNA Labs UAE, designed to accurately identify genetic markers associated with Usher Syndrome. Usher Syndrome is a rare genetic disorder that leads to a combination of hearing loss and visual impairment, significantly affecting the quality of life. This test utilizes next-generation sequencing technology to analyze the patient's DNA, targeting specific genes known to be linked with the syndrome, providing a comprehensive understanding of the genetic mutations present.
At a cost of 5730 AED, the test is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring high precision and reliability. It is particularly valuable for individuals with a family history of Usher Syndrome or those exhibiting symptoms, offering crucial insights for early intervention and management strategies. By opting for this advanced genetic test, patients and healthcare providers can make informed decisions regarding future healthcare plans, potentially mitigating the progression of symptoms associated with Usher Syndrome.
The Oncopro Colorectal Cancer Screen is a cutting-edge diagnostic test designed to detect circulating tumor cells (CTCs) in the bloodstream, which are indicative of colorectal cancer. This non-invasive test offers a promising approach for early detection of colorectal cancer, potentially even before symptoms appear or when the cancer is in its initial stages. Circulating tumor cells are cancer cells that have detached from the primary tumor and circulate in the bloodstream, aiming to form metastases in other organs. The presence of these cells can be a crucial indicator of the spread of cancer, making their detection a valuable tool in cancer management and prognosis.
Performed at DNA Labs UAE, a leading facility in medical diagnostics, the test leverages advanced technology to accurately identify and quantify circulating tumor cells. This innovative approach not only aids in the early detection of colorectal cancer but also helps in monitoring the disease's progression and evaluating the effectiveness of ongoing treatments. It is a significant advancement in the realm of personalized medicine, allowing for tailored treatment strategies based on the patient's specific cancer profile.
The test cost is set at 5730 AED, reflecting the sophisticated technology and expertise required to conduct this advanced diagnostic procedure. While the cost might seem high, the value it provides in terms of early detection, personalized treatment plans, and potentially improved outcomes can be immeasurable for individuals at risk of or battling colorectal cancer. Early detection through tests like the Oncopro Colorectal Cancer Screen can significantly increase the chances of successful treatment and survival, making it a potentially life-saving investment.
The Oncopro Prostate Cancer Screen Test is a specialized diagnostic tool designed to detect the presence of prostate cancer at an early stage. This advanced screening test is available at DNA Labs UAE, a leading facility in genetic and molecular diagnostics. The test works by analyzing specific markers that are often associated with prostate cancer, providing a non-invasive yet highly accurate assessment of an individual's risk for developing this type of cancer.
Priced at 5620 AED, the Oncopro Prostate Cancer Screen Test is a valuable investment for men, especially those who are at an increased risk due to factors such as age, family history, or genetic predispositions. By opting for this screening, individuals can gain crucial insights into their health, enabling early detection and the possibility of more effective treatment options if needed.
DNA Labs UAE is renowned for its state-of-the-art facilities and commitment to providing accurate, reliable, and timely diagnostic services. Choosing to undergo the Oncopro Prostate Cancer Screen Test at DNA Labs UAE means entrusting your health to experienced professionals who use cutting-edge technology to deliver comprehensive and personalized health insights.
The Mitochondrial Mutation Detection Comprehensive Panel Test, offered by DNA Labs UAE, is a sophisticated diagnostic tool designed to identify mutations within the mitochondrial DNA (mtDNA). This test is particularly significant for individuals experiencing symptoms or with a family history of mitochondrial disorders, as it helps in the accurate diagnosis of such conditions. Mitochondrial diseases can manifest in various forms and affect multiple systems of the body, making early and precise detection crucial for effective management and treatment.
Priced at 5620 AED, the test employs advanced genetic sequencing technologies to examine the entire mitochondrial genome. This thorough analysis enables the identification of both common and rare mutations that could lead to mitochondrial dysfunction. By pinpointing the specific genetic alterations responsible for a patient's condition, healthcare providers can tailor treatment strategies more effectively, offer prognostic insights, and advise on the risk of passing the condition to future generations.
Conducted at DNA Labs UAE, a facility known for its cutting-edge genetic testing services, the Mitochondrial Mutation Detection Comprehensive Panel Test is a testament to the lab's commitment to providing high-quality, accurate diagnostic solutions. Patients opting for this test can expect professional service, confidentiality, and comprehensive support throughout the testing process.
The "Nx Gen Sequencing Maturity Onset Diabetes of Young (MODY) Test" offered by DNA Labs UAE represents a cutting-edge diagnostic approach for identifying the genetic mutations associated with MODY, a form of diabetes that typically manifests before the age of 25. MODY is characterized by its monogenic nature, meaning it results from mutations in a single gene, distinguishing it from the more common types of diabetes which are polygenic. This advanced test leverages Next Generation Sequencing (NGS) technology, allowing for the comprehensive analysis of multiple genes simultaneously with high accuracy and speed.
The MODY test is particularly crucial for individuals with a family history of diabetes or those exhibiting symptoms of diabetes at an unusually young age. Early and accurate diagnosis through this test can lead to personalized treatment plans, significantly improving the management of the condition and enhancing the quality of life for those affected.
At a cost of 5620 AED, the test is an investment in precision medicine, enabling healthcare providers to tailor interventions based on the specific genetic mutation present. Conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services, clients are assured of receiving reliable and comprehensive diagnostic insights that can guide the management of MODY.
The Oncopro Pan Cancer Monitor Test, available at DNA Labs UAE for a cost of 6080 AED, represents a cutting-edge advancement in the realm of cancer diagnostics and monitoring. This comprehensive test is designed to detect and monitor various types of cancer through a minimally invasive approach, using a simple blood sample to analyze circulating tumor DNA (ctDNA). By identifying specific genetic mutations and alterations associated with cancer, the Oncopro Pan Cancer Monitor Test offers a personalized and dynamic insight into the patient's disease status, helping to guide treatment decisions, monitor response to therapy, and detect potential relapse at an early stage. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test is a pivotal tool in the precision medicine approach to cancer care, providing crucial information for both patients and healthcare providers in the management of the disease.
The "Acute Leukemia Diagnostic Comprehensive Profile Test," offered at DNA Labs UAE, is a specialized diagnostic tool designed to accurately identify and classify acute leukemia in patients. Priced at 5850 AED, this comprehensive test is crucial for the early detection and management of acute leukemia, a rapidly progressing cancer that affects the blood and bone marrow.
This test encompasses a range of diagnostic procedures aimed at identifying the specific type of leukemia, including its genetic markers, and the stage of the disease. By analyzing various blood components and bone marrow samples, the test provides healthcare professionals with essential information that guides treatment planning and prognosis estimation.
DNA Labs UAE utilizes advanced technology and methodologies to ensure high accuracy and reliability of the test results. The insights gained from the Acute Leukemia Diagnostic Comprehensive Profile Test enable personalized treatment approaches, potentially improving patient outcomes and survival rates.
The Chromofic Karyoarray Test, available at DNA Labs UAE for a cost of 5850 AED, is a cutting-edge diagnostic tool designed to analyze chromosomal abnormalities with high precision. This test employs the latest microarray technology to examine the entire genome, enabling the detection of various genetic disorders and conditions. Unlike traditional karyotyping, which provides a broader view of chromosomes, the Chromofic Karyoarray Test can identify much smaller changes in the DNA, such as deletions, duplications, and other structural variations that could be responsible for genetic diseases. This makes it an invaluable tool for genetic counseling, prenatal screening, and diagnosing unexplained developmental delays or intellectual disabilities in individuals. The test is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring accurate and reliable results.
